DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $366,356 | +16.0% | 1,477 | +12.2% | 0.17% | +26.9% |
Q2 2023 | $315,724 | -4.3% | 1,316 | +0.5% | 0.13% | -11.8% |
Q1 2023 | $330,002 | -4.7% | 1,309 | +0.3% | 0.15% | -8.4% |
Q4 2022 | $346,417 | +2.5% | 1,305 | -0.2% | 0.17% | -9.8% |
Q3 2022 | $338,000 | -1.5% | 1,307 | -3.3% | 0.18% | +0.5% |
Q2 2022 | $343,000 | -19.9% | 1,352 | -7.5% | 0.18% | +2.8% |
Q1 2022 | $428,000 | -45.3% | 1,461 | -38.5% | 0.18% | -43.3% |
Q4 2021 | $782,000 | -0.8% | 2,377 | -8.2% | 0.31% | -7.1% |
Q3 2021 | $788,000 | +91.3% | 2,589 | +68.7% | 0.34% | +252.1% |
Q2 2021 | $412,000 | -39.8% | 1,535 | -49.5% | 0.10% | -34.2% |
Q1 2021 | $684,000 | -4.2% | 3,042 | -5.4% | 0.15% | -18.4% |
Q4 2020 | $714,000 | +3.2% | 3,216 | +0.1% | 0.18% | -4.8% |
Q3 2020 | $692,000 | +20.1% | 3,214 | -1.3% | 0.19% | +16.8% |
Q2 2020 | $576,000 | +24.9% | 3,256 | -2.2% | 0.16% | +21.1% |
Q1 2020 | $461,000 | -11.0% | 3,328 | -1.5% | 0.13% | -0.7% |
Q4 2019 | $518,000 | – | 3,378 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |